Crystalline Management »

Xeris Pharmaceuticals shares owned by Crystalline Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Crystalline Management from 13F filings

Historical chart of Crystalline Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Crystalline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Crystalline Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $37k 17k 2.21

More positions owned by Crystalline Management

Altair Engr Note 1.750% 6/1 (Principal)
Enerplus Corp (ERF)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Mountain & Co I Acquisitn Class A Ord (MCAA)
Monterey Cap Acquisition Cor Class A Com (MCAC)
Hollysys Automation Tchngy L SHS (HOLI)
Ap Acquisition Corp Cl A Ord Shs (APCA)
Global Star Acquisition Class A Com (GLST)
Axonics Modulation Technolog (AXNX)
Ix Acquisition Corp Class A Ord Shs (IXAQ)
Tlgy Acquisition Corporation Class A Ord Shs (TLGY)
Oca Acquisition Corp Com Cl A (OCAX)
Daseke (DSKE)
Learn Cw Investment Cor Cl A Ord Shs (LCW)
Hudson Acquisition I Corp Common Stock (HUDA)

View all positions for Crystalline Management

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
MPM Oncology Impact Management
Geode Capital Management
Rosalind Advisors
Millennium Management
Nuveen Asset Management
CenterBook Partners
Morgan Stanley
Northern Trust
AQR Capital Management
Redmile Group
Ameriprise Financial
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Xeris Pharmaceuticals